{
    "accountDetails": {
        "accountHasCodexViolations": false,
        "activeDateRanges": [
            {
                "fromDate": "2022-11-29T15:07:48.000+01:00",
                "untilDate": "2024-07-02T00:12:06.000+02:00"
            },
            {
                "fromDate": "2024-07-03T12:22:00.000+02:00"
            }
        ],
        "firstPublicationDate": "2022-03-04T16:02:49.000+01:00",
        "inactiveDateRanges": [
            {
                "fromDate": "2024-07-02T00:12:06.000+02:00",
                "untilDate": "2024-07-03T12:22:00.000+02:00"
            }
        ],
        "lastUpdateDate": "2024-07-03T12:22:00.000+02:00",
        "registerEntryVersions": [
            {
                "legislation": "GL2024",
                "registerEntryId": 40805,
                "validFromDate": "2024-07-03T12:22:00.000+02:00",
                "version": 5,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 40844,
                "validFromDate": "2024-07-02T00:12:06.000+02:00",
                "validUntilDate": "2024-07-03T12:22:00.000+02:00",
                "version": 4,
                "versionActiveLobbyist": false
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 19999,
                "validFromDate": "2023-05-22T16:06:39.000+02:00",
                "validUntilDate": "2024-07-02T00:12:06.000+02:00",
                "version": 3,
                "versionActiveLobbyist": true
            },
            {
                "legislation": "GL2022",
                "registerEntryId": 13619,
                "validFromDate": "2022-11-29T15:07:48.000+01:00",
                "validUntilDate": "2023-05-22T16:06:39.000+02:00",
                "version": 2,
                "versionActiveLobbyist": true
            }
        ]
    },
    "activeLobbyist": true,
    "activitiesAndInterests": {
        "activity": {
            "code": "ACT_ORGANIZATION_V2",
            "de": "Sonstiges Unternehmen",
            "en": "Other company"
        },
        "activityDescription": "Die APOGEPHA Arzneimittel GmbH ist ein mittelst\u00e4ndisches Familienunternehmen, das sich auf die Entwicklung und Vermarktung urologischer Arzneimittel, Medizinprodukte und digitaler Gesundheitsanwendungen spezialisiert hat. Im Interesse einer nachhaltigen Unternehmensentwicklung und der Sicherstellung einer qualitativ hochwertigen Gesundheitsversorgung suchen wir den Austausch mit Vertretern der Gesundheits- und Wirtschaftspolitik. Unser Ziel ist es, als Arzneimittelanbieter und Gesundheitsunternehmen einen wertvollen Beitrag im Gesundheitssystem zu leisten und in diesem Sinne Vorschl\u00e4ge, Interessen und Perspektiven des pharmazeutischen Mittelstandes in die politische Diskussion einzubringen.         ",
        "fieldsOfInterest": [
            {
                "code": "FOI_ECONOMY",
                "de": "Wirtschaft",
                "en": "Economy"
            },
            {
                "code": "FOI_HEALTH",
                "de": "Gesundheit",
                "en": "Health"
            },
            {
                "code": "FOI_ECONOMY_SAM_BUSINESS",
                "de": "Kleine und mittlere Unternehmen",
                "en": "Small and medium business"
            },
            {
                "code": "FOI_SCIENCE_RESEARCH_TECHNOLOGY",
                "de": "Wissenschaft, Forschung und Technologie",
                "en": "Science, research and technology"
            },
            {
                "code": "FOI_HEALTH_MEDICINE",
                "de": "Arzneimittel",
                "en": "Medicine"
            },
            {
                "code": "FOI_HEALTH_OTHER",
                "de": "Sonstiges im Bereich \"Gesundheit\"",
                "en": "Other in the field of \"Health\""
            }
        ],
        "typesOfExercisingLobbyWork": [
            {
                "code": "SELF_OPERATED_OWN_INTEREST",
                "de": "Die Interessenvertretung wird in eigenem Interesse selbst wahrgenommen",
                "en": "Interest representation is self-performed in its own interest"
            }
        ]
    },
    "annualReports": {
        "annualReportPdfUrl": "https://www.lobbyregister.bundestag.de/media/39/a5/330131/JA-APOGEPHA-Unternehmensregister_2022.pdf",
        "annualReportPreviousLastFiscalYearExists": true,
        "relatedFiscalYearEnd": "2022-12-31",
        "relatedFiscalYearStart": "2022-01-01"
    },
    "codeOfConduct": {
        "ownCodeOfConduct": false
    },
    "contracts": {
        "contracts": [],
        "contractsPresent": false
    },
    "donators": {
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalDonationsEuro": {
            "from": 0,
            "to": 0
        }
    },
    "employeesInvolvedInLobbying": {
        "employeeFTE": 1.25,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "financialExpenses": {
        "financialExpensesEuro": {
            "from": 10001,
            "to": 20000
        },
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "legislation": "GL2024",
    "lobbyistIdentity": {
        "address": {
            "city": "Dresden",
            "country": {
                "code": "DE",
                "de": "Deutschland",
                "en": "Germany"
            },
            "nationalAdditional1": "APOGEPHA Arzneimittel GmbH",
            "street": "Kyffh\u00e4userstra\u00dfe",
            "streetNumber": "27",
            "type": "NATIONAL",
            "zipCode": "01309"
        },
        "capitalCityRepresentationPresent": false,
        "contactDetails": {
            "emails": [
                {
                    "email": "sliebig@apogepha.de"
                },
                {
                    "email": "beitzenberger@apogepha.de"
                }
            ],
            "phoneNumber": "+493513363497",
            "websites": [
                {
                    "website": "www.apogepha.de"
                }
            ]
        },
        "entrustedPersons": [
            {
                "firstName": "Steffi",
                "lastName": "Liebig",
                "recentGovernmentFunctionPresent": false
            },
            {
                "firstName": "Henriette",
                "lastName": "Starke",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "entrustedPersonsPresent": true,
        "identity": "ORGANIZATION",
        "legalForm": {
            "code": "LF_GMBH",
            "de": "Gesellschaft mit beschr\u00e4nkter Haftung (GmbH)",
            "en": "Limited liability company (GmbH)"
        },
        "legalFormType": {
            "code": "JURISTIC_PERSON",
            "de": "Juristische Person",
            "en": "Legal person"
        },
        "legalRepresentatives": [
            {
                "academicDegreeBefore": "Dr. rer. nat.",
                "entrustedPerson": false,
                "firstName": "Dirk",
                "function": "Gesch\u00e4ftsf\u00fchrer",
                "lastName": "Pamperin",
                "recentGovernmentFunctionPresent": false
            },
            {
                "academicDegreeBefore": "Dr. ",
                "entrustedPerson": false,
                "firstName": "Alexandra",
                "function": "Gesch\u00e4ftsf\u00fchrerin Marketing und Vertrieb",
                "lastName": "Pries",
                "recentGovernmentFunctionPresent": false
            },
            {
                "entrustedPerson": false,
                "firstName": "Andreas",
                "function": "Gesch\u00e4ftsf\u00fchrer Finanzen und Controlling",
                "lastName": "Ott",
                "recentGovernmentFunctionPresent": false
            }
        ],
        "membersPresent": false,
        "memberships": [
            {
                "membership": "Pharma Deutschland e.V. "
            },
            {
                "membership": "Bundesverband der Pharmazeutischen Industrie e.V. (BPI)"
            },
            {
                "membership": "Wirtschaftsrat der CDU e.V."
            },
            {
                "membership": "Arzneimittel und Kooperation im Gesundheitswesen AKG e.V. "
            },
            {
                "membership": "Verband der Chemischen Industrie e. V. (VCI)"
            }
        ],
        "membershipsPresent": true,
        "name": "APOGEPHA Arzneimittel GmbH"
    },
    "mainFundingSources": {
        "mainFundingSources": [
            {
                "code": "MFS_ECONOMIC_ACTIVITY",
                "de": "Wirtschaftliche T\u00e4tigkeit",
                "en": "Economic activity"
            }
        ],
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "membershipFees": {
        "individualContributors": [],
        "individualContributorsPresent": false,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01",
        "totalMembershipFees": {
            "from": 0,
            "to": 0
        }
    },
    "publicAllowances": {
        "publicAllowances": [
            {
                "description": "voraussichtliche Forschungszulage f\u00fcr das Gesch\u00e4ftsjahr 2023",
                "location": "Finanzamt Dresden",
                "name": "Forschungszulage gem\u00e4\u00df Forschungszulagengesetz",
                "publicAllowanceEuro": {
                    "from": 140001,
                    "to": 150000
                },
                "type": {
                    "code": "GERMAN_PUBLIC_SECTOR_MUNICIPALITY",
                    "de": "Deutsche \u00d6ffentliche Hand \u2013 Kommune",
                    "en": "German Public Sector \u2013 Municipality"
                }
            },
            {
                "description": "F\u00f6rderung Beratung E-Commerce",
                "location": "Sachsen",
                "name": "SAB Sachsen",
                "publicAllowanceEuro": {
                    "from": 10001,
                    "to": 20000
                },
                "type": {
                    "code": "GERMAN_PUBLIC_SECTOR_LAND",
                    "de": "Deutsche \u00d6ffentliche Hand \u2013 Land",
                    "en": "German Public Sector \u2013 Land"
                }
            }
        ],
        "publicAllowancesPresent": true,
        "relatedFiscalYearEnd": "2023-12-31",
        "relatedFiscalYearFinished": true,
        "relatedFiscalYearStart": "2023-01-01"
    },
    "registerEntryDetails": {
        "detailsPageUrl": "https://www.lobbyregister.bundestag.de/suche/R002951/40805",
        "fiscalYearUpdate": {
            "lastFiscalYearUpdate": "2024-07-03T12:22:00.000+02:00"
        },
        "pdfUrl": "https://www.lobbyregister.bundestag.de/media/da/0f/330134/Lobbyregister-Detailansicht-R002951-2024-07-03_12-22-00.pdf",
        "validFromDate": "2024-07-03T12:22:00.000+02:00",
        "version": 5
    },
    "registerEntryId": 40805,
    "registerNumber": "R002951",
    "regulatoryProjects": {
        "regulatoryProjects": [
            {
                "affectedLaws": [
                    {
                        "shortTitle": "SGB 5",
                        "title": "Sozialgesetzbuch (SGB) F\u00fcnftes Buch (V) - Gesetzliche Krankenversicherung - (Artikel 1 des Gesetzes v. 20. Dezember 1988, BGBl. I S. 2477)",
                        "url": "https://www.gesetze-im-internet.de/sgb_5"
                    }
                ],
                "affectedLawsPresent": true,
                "description": "ALBVVG in Kraft (BGBl. 2023 I Nr. 197 vom 26.07.2023); Themen sind v.a.: Verstetigung Regelungen Kinderarzneimittel-Liste nach \u00a7 35a SGB V; Erweiterung der Ausnahmen von FB, Preismoratorium und Rabattvertr\u00e4gen f\u00fcr ausgew\u00e4hlte (v.a. versorgungskritische) Wirkstoffe sowie St\u00e4rkung des Produktionsstandortes DE, EU; Vereinfachung der Meldepflichten und Harmonisierung mit EU-Vorgaben (B\u00fcrokratieabbau); Streichung der AMNOG-Leitplanken",
                "draftBillPresent": false,
                "fieldsOfInterest": [
                    {
                        "code": "FOI_HEALTH",
                        "de": "Gesundheit",
                        "en": "Health"
                    },
                    {
                        "code": "FOI_HEALTH_MEDICINE",
                        "de": "Arzneimittel",
                        "en": "Medicine"
                    },
                    {
                        "code": "FOI_HEALTH_OTHER",
                        "de": "Sonstiges im Bereich \"Gesundheit\"",
                        "en": "Other in the field of \"Health\""
                    },
                    {
                        "code": "FOI_SCIENCE_RESEARCH_TECHNOLOGY",
                        "de": "Wissenschaft, Forschung und Technologie",
                        "en": "Science, research and technology"
                    },
                    {
                        "code": "FOI_ECONOMY",
                        "de": "Wirtschaft",
                        "en": "Economy"
                    },
                    {
                        "code": "FOI_ECONOMY_SAM_BUSINESS",
                        "de": "Kleine und mittlere Unternehmen",
                        "en": "Small and medium business"
                    }
                ],
                "printedMatters": [],
                "printedMattersPresent": false,
                "regulatoryProjectNumber": "RV0010788",
                "statements": [],
                "title": "Sozialgesetzbuch V"
            }
        ],
        "regulatoryProjectsPresent": true
    },
    "statements": {
        "statements": [],
        "statementsPresent": false
    }
}